New potent steroid sulphatase inhibitors based on 6-(1-phenyl-1


Journal

Journal of enzyme inhibition and medicinal chemistry
ISSN: 1475-6374
Titre abrégé: J Enzyme Inhib Med Chem
Pays: England
ID NLM: 101150203

Informations de publication

Date de publication:
Dec 2021
Historique:
entrez: 16 12 2020
pubmed: 17 12 2020
medline: 25 6 2021
Statut: ppublish

Résumé

In the present work, we report a new class of potent steroid sulphatase (STS) inhibitors based on 6-(1-phenyl-1

Identifiants

pubmed: 33322953
doi: 10.1080/14756366.2020.1858820
pmc: PMC7744152
doi:

Substances chimiques

Enzyme Inhibitors 0
Sulfonic Acids 0
sulfamic acid 9NFU33906Q
Steryl-Sulfatase EC 3.1.6.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

238-247

Références

J Steroid Biochem Mol Biol. 2000 Dec 31;75(4-5):253-8
pubmed: 11282279
Breast Cancer Res Treat. 2017 Sep;165(2):343-353
pubmed: 28612226
Breast Cancer Res Treat. 2017 Nov;166(2):527-539
pubmed: 28795252
Eur J Med Chem. 2019 Oct 1;179:257-271
pubmed: 31255926
Bioorg Med Chem. 2018 Jul 15;26(11):2921-2927
pubmed: 29784271
Bioorg Med Chem Lett. 2018 Apr 1;28(6):1143-1148
pubmed: 29486966
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Mol Cell Endocrinol. 2011 Jul 4;340(2):154-60
pubmed: 21693170
J Asian Nat Prod Res. 2020 Nov;22(11):1037-1044
pubmed: 31773975
Expert Rev Anticancer Ther. 2011 Feb;11(2):179-83
pubmed: 21342037
Endocr Rev. 2005 Apr;26(2):171-202
pubmed: 15561802
Biochemistry. 1995 Sep 12;34(36):11508-14
pubmed: 7547880
Biochim Biophys Acta. 2004 Jun 7;1654(2):123-43
pubmed: 15172700
Endocr Relat Cancer. 2004 Dec;11(4):643-58
pubmed: 15613444
J Med Chem. 2018 May 10;61(9):4256-4262
pubmed: 29676909
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Breast Cancer Res Treat. 2010 Apr;120(3):639-48
pubmed: 20151319
Clin Cancer Res. 2008 Oct 15;14(20):6469-77
pubmed: 18927286
Eur J Med Chem. 2016 May 23;114:170-90
pubmed: 26974384
Bioorg Med Chem. 2019 Aug 15;27(16):3511-3531
pubmed: 31300317
Clin Cancer Res. 2006 Mar 1;12(5):1585-92
pubmed: 16533785
Anticancer Agents Med Chem. 2008 Oct;8(7):732-8
pubmed: 18855575
J Mol Endocrinol. 2018 Aug;61(2):T233-T252
pubmed: 29618488
Chem Biol. 2000 Oct;7(10):773-91
pubmed: 11033081
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1163-1184
pubmed: 32363947
Eur J Med Chem. 2018 Jan 1;143:1010-1020
pubmed: 29232578
J Steroid Biochem Mol Biol. 2001 Nov;78(5):441-50
pubmed: 11738554

Auteurs

Olga Ciupak (O)

Department of Organic Chemistry, Faculty of Chemistry, Gdańsk University of Technology, Gdańsk, Poland.

Mateusz Daśko (M)

Department of Inorganic Chemistry, Faculty of Chemistry, Gdańsk University of Technology, Gdańsk, Poland.

Karol Biernacki (K)

Department of Organic Chemistry, Faculty of Chemistry, Gdańsk University of Technology, Gdańsk, Poland.

Janusz Rachon (J)

Department of Organic Chemistry, Faculty of Chemistry, Gdańsk University of Technology, Gdańsk, Poland.

Maciej Masłyk (M)

Department of Molecular Biology, The John Paul II Catholic University of Lublin, Lublin, Poland.

Konrad Kubiński (K)

Department of Molecular Biology, The John Paul II Catholic University of Lublin, Lublin, Poland.

Aleksandra Martyna (A)

Department of Molecular Biology, The John Paul II Catholic University of Lublin, Lublin, Poland.

Sebastian Demkowicz (S)

Department of Organic Chemistry, Faculty of Chemistry, Gdańsk University of Technology, Gdańsk, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH